Table 3.
|
Luminal A |
Luminal B |
HER2 |
TNBC |
p |
||||
---|---|---|---|---|---|---|---|---|---|
|
(N = 64) |
(N = 120) |
(N = 39) |
(N = 46) |
|
||||
|
Nr |
% |
Nr |
% |
Nr |
% |
Nr |
% |
|
Stage | |||||||||
IA |
12 |
26.67 |
29 |
29.29 |
6 |
20.69 |
4 |
10.26 |
0.4960 |
IIA |
13 |
28.89 |
34 |
34.35 |
7 |
24.14 |
14 |
35.90 |
|
IIB |
8 |
17.78 |
16 |
16.16 |
9 |
31.03 |
10 |
25.64 |
|
IIIA |
2 |
4.44 |
6 |
6.06 |
1 |
3.45 |
3 |
7.69 |
|
IIIC |
1 |
2.22 |
- |
- |
1 |
3.45 |
- |
- |
|
IV |
9 |
20.00 |
14 |
14.14 |
5 |
17.24 |
8 |
20.51 |
|
Total |
45 |
|
99 |
|
29 |
|
39 |
|
|
n/a |
19 |
|
21 |
|
10 |
|
7 |
|
|
|
Adjuvant chemotherapy |
||||||||
Yes |
34 |
54.84 |
72 |
61.02 |
32 |
86.49 |
27 |
62.79 |
0.0131 |
No |
28 |
45.16 |
46 |
38.98 |
5 |
13.51 |
16 |
37.21 |
|
|
Radiotherapy |
||||||||
Yes |
49 |
79.03 |
99 |
83.90 |
33 |
89.19 |
42 |
97.67 |
0.0462 |
No |
13 |
20.97 |
19 |
16.10 |
4 |
10.81 |
1 |
2.33 |
|
|
Hormone therapy |
||||||||
Yes |
47 |
75.81 |
87 |
82.20 |
- |
- |
- |
- |
<0.0001 |
No |
15 |
24.19 |
21 |
17.80 |
37 |
100.0 |
43 |
100.0 |
|
n/a | 2 | 2 | 2 | 3 |
n/a = not available.